OXB Appoints Joachim Kreuzburg as Independent Non-Executive Director

OXB, a global cell and gene therapy CDMO, has appointed Dr Joachim Kreuzburg as an Independent Non-Executive Director effective November 23, 2026. Kreuzburg brings over 20 years of life sciences leadership experience, having previously served as CEO of Sartorius AG, where he transformed the company and grew its valuation from €90 million to €14 billion through strategic acquisitions and innovation.